1. Organization, W.H. Depressive disorder (depression). 2023 31 March 2023 (cited 2023 4 March); Available from: https://www.who.int/news-room/fact-sheets/detail/depression.

2. Organization, W.H. Anxiety disorders. 2023 27 September 2023; Available from: https://www.who.int/news-room/fact-sheets/detail/anxiety-disorders.

3. Loscalzo J, F.A., Kasper D, Hauser S, Longo D, Jameson J. Loscalzo J, & Fauci A, & Kasper D, & Hauser S, & Longo D, & Jameson J(Eds.),Eds. Joseph Loscalzo, et al, Approach to the Patient with Cancer, in Harrison's principles of internal medicine, D.L. Longo, Editor. 2022, McGraw-Hill Education Medical: New York. p. 487.

4. Peng YN, H.M., Kao CH, Prevalence of Depression and Anxiety in Colorectal Cancer Patients: A Literature Review. Int J Environ Res Public Health, 2019. [DOI:10.3390/ijerph16030411]

5. Loscalzo J, F.A., Kasper D, Hauser S, Longo D, Jameson J. Loscalzo J, & Fauci A, & Kasper D, & Hauser S, & Longo D, & Jameson J(Eds.),Eds. Joseph Loscalzo, et al, Lower Gastrointestinal Cancers, R.J. Mayer, Editor. 2022, McGraw-Hill Education Medical: New York.

6. Gholamreza Roshandel, J.F., Ali Ghanbari-Motlagh, Elham Partovipour, Fereshteh Salavati, Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden. Cancer Epidemiology, 2008-2021.

7. Christakos, S., et al., Vitamin D: Metabolism, Molecular Mechanism of Action and Pleiotropic Effects. Physiol Rev, 2016. 96(1): p. 365-408. [DOI:10.1152/physrev.00014.2015]

8. Eyles, D.W., T.H. Burne and J.J. McGrath, Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol, 2013. 34(1): p. 47-64. [DOI:10.1016/j.yfrne.2012.07.001]

9. Ferrer-Mayorga, G., et al., Mechanisms of action of vitamin D in colon cancer. J Steroid Biochem Mol Biol, 2019. 185: p. 1-6. [DOI:10.1016/j.jsbmb.2018.07.002]

10. Kong, J., et al., Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol, 2008. 294(1): p. G208-16. [DOI:10.1152/ajpgi.00398.2007]

11. Boontanrart, M., et al., Vitamin D3 alters microglia immune activation by an IL-10 dependent SOCS3 mechanism. J Neuroimmunol, 2016. 292: p. 126-36. [DOI:10.1016/j.jneuroim.2016.01.015]

12. Wimalawansa, S.J., M.S. Razzaque and N.M. Al-Daghri, Calcium and vitamin D in human health: Hype or real? J Steroid Biochem Mol Biol, 2018. 180: p. 4-14. [DOI:10.1016/j.jsbmb.2017.12.009]

13. van Schoor, N.M. and P. Lips, Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab, 2011. 25(4): p. 671-80. [DOI:10.1016/j.beem.2011.06.007]

14. Jääskeläinen, T., et al., Higher serum 25-hydroxyvitamin D concentrations are related to a reduced risk of depression. Br J Nutr, 2015. 113(9): p. 1418-26. [DOI:10.1017/S0007114515000689]

15. Vidgren, M., et al., Serum Concentrations of 25-Hydroxyvitamin D and Depression in a General Middle-Aged to Elderly Population in Finland. J Nutr Health Aging, 2018. 22(1): p. 159-164. [DOI:10.1007/s12603-017-0948-6]

16. Briggs, R., et al., Vitamin D Deficiency Is Associated With an Increased Likelihood of Incident Depression in Community-Dwelling Older Adults. J Am Med Dir Assoc, 2019. 20(5): p. 517-523. [DOI:10.1016/j.jamda.2018.10.006]

17. Pu, D., et al., Prevalence of depression and anxiety in rheumatoid arthritis patients and their associations with serum vitamin D level. Clin Rheumatol, 2018. 37(1): p. 179-184. [DOI:10.1007/s10067-017-3874-4]

18. Karonova, T.L., et al., (Anxiety/depressive disorders and vitamin D status). Zh Nevrol Psikhiatr Im S S Korsakova, 2015. 115(10 Pt 2): p. 55-58. [DOI:10.17116/jnevro201511510255-58]

19. Bičíková, M., et al., Vitamin D in anxiety and affective disorders. Physiol Res, 2015. 64(Suppl 2): p. S101-3. [DOI:10.33549/physiolres.933082]

20. Han, B., et al., Low serum levels of vitamin D are associated with anxiety in children and adolescents with dialysis. Sci Rep, 2018. 8(1): p. 5956. [DOI:10.1038/s41598-018-24451-7]

21. Casseb GAS, K.M., Rodrigues ALS, Potential Role of Vitamin D for the Management of Depression and Anxiety. CNS drugs, 2019. [DOI:10.1007/s40263-019-00640-4]

22. Stokes, C.S. and F. Lammert, Vitamin D supplementation: less controversy, more guidance needed. F1000Res, 2016. 5. [DOI:10.12688/f1000research.8863.1]

23. Aloia, J.F., et al., Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr, 2008. 87(6): p. 1952-8. [DOI:10.1093/ajcn/87.6.1952]

24. Zung, W.W., A self-rating depression scale. Archives of general psychiatry, 1965. 12(1): p. 63-70. [DOI:10.1001/archpsyc.1965.01720310065008]

25. Safaralizadeh, F., H. Partovazam and A. Habibpoor, The correlation between depression and body mass index in female teenagers of khoy during year 2009. Community Health Journal, 2017. 5(1): p. 17-24.

26. Zung, W.W., A rating instrument for anxiety disorders. Psychosomatics: Journal of Consultation and Liaison Psychiatry, 1971. [DOI:10.1016/S0033-3182(71)71479-0]

27. Hossein-Sabet, F., Effectiveness of patience training in anxiety, depression and happiness. Studies in Islam and Psychology, 2008. 2(2): p. 79-93.

28. Loscalzo J, F.A., Kasper D, Hauser S, Longo D, Jameson J. Loscalzo J, & Fauci A, & Kasper D, & Hauser S, & Longo D, & Jameson J(Eds.),Eds. Joseph Loscalzo, et al, Vitamin and Trace Mineral Deficiency and Excess, in Harrison's principles of internal medicine, R. V, Editor. 2022, McGraw-Hill Education Medical: United States. New York. p. 2531.

29. Dawson-Hughes, B., Vitamin D deficiency in adults: Definition, clinical manifestations and treatment. 2022, Wolters Kluwer Health: Waltham, MA.

30. May, H.T., et al., Association of vitamin D levels with incident depression among a general cardiovascular population. Am Heart J, 2010. 159(6): p. 1037-43. [DOI:10.1016/j.ahj.2010.03.017]

31. Moy, F.M., et al., Vitamin D deficiency and depression among women from an urban community in a tropical country. Public Health Nutr, 2017. 20(10): p. 1844-1850. [DOI:10.1017/S1368980016000811]

32. Parker, G. and H. Brotchie, Mood effects of the amino acids tryptophan and tyrosine: 'Food for Thought' III. Acta Psychiatr Scand, 2011. 124(6): p. 417-26. [DOI:10.1111/j.1600-0447.2011.01706.x]

33. Chan, R., et al., Association between serum 25-hydroxyvitamin D and psychological health in older Chinese men in a cohort study. Journal of affective disorders, 2011. 130(1-2): p. 251-259. [DOI:10.1016/j.jad.2010.10.029]

34. Prüfer, K., et al., Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J Chem Neuroanat, 1999. 16(2): p. 135-45. [DOI:10.1016/S0891-0618(99)00002-2]

35. Mora, J.R., M. Iwata and U.H. von Andrian, Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol, 2008. 8(9): p. 685-98. [DOI:10.1038/nri2378]

36. van Etten, E., et al., Regulation of vitamin D homeostasis: implications for the immune system. Nutr Rev, 2008. 66(10 Suppl 2): p. S125-34. [DOI:10.1111/j.1753-4887.2008.00096.x]

37. Buell, J.S. and B. Dawson-Hughes, Vitamin D and neurocognitive dysfunction: preventing "D"ecline? Mol Aspects Med, 2008. 29(6): p. 415-22. [DOI:10.1016/j.mam.2008.05.001]

38. Song, C. and H. Wang, Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry, 2011. 35(3): p. 760-8. [DOI:10.1016/j.pnpbp.2010.06.020]

39. Somoza-Moncada, M.M., et al., Vitamin D in Depression: A Potential Bioactive Agent to Reduce Suicide and Suicide Attempt Risk. Nutrients, 2023. 15(7). [DOI:10.3390/nu15071765]

40. Eyles, D.W., et al., Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat, 2005. 29(1): p. 21-30. [DOI:10.1016/j.jchemneu.2004.08.006]

41. Dogan-Sander, E., et al., Inflammation and the Association of Vitamin D and Depressive Symptomatology. Nutrients, 2021. 13(6). [DOI:10.3390/nu13061972]

42. Costello, H., et al., Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder. BMJ Open, 2019. 9(7): p. e027925. [DOI:10.1136/bmjopen-2018-027925]

43. Kumari, N., et al., Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol, 2016. 37(9): p. 11553-11572. [DOI:10.1007/s13277-016-5098-7]

44. Kampan, N.C., et al., Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities. Curr Med Chem, 2018. 25(36): p. 4785-4806. [DOI:10.2174/0929867324666170712160621]

45. Glover, A.T., et al., Can inflammation be an independent predictor of depression? Brain Behav Immun, 2010. 24(2): p. 173; author reply 174-5. [DOI:10.1016/j.bbi.2009.11.008]

46. Köhler, C.A., et al., Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand, 2017. 135(5): p. 373-387. [DOI:10.1111/acps.12698]

47. Haapakoski, R., et al., Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav Immun, 2015. 49: p. 206-15. [DOI:10.1016/j.bbi.2015.06.001]

48. Howren, M.B., D.M. Lamkin and J. Suls, Associations of depression with C-reactive protein, IL-1 and IL-6: a meta-analysis. Psychosom Med, 2009. 71(2): p. 171-86. [DOI:10.1097/PSY.0b013e3181907c1b]

49. Dowlati, Y., et al., A meta-analysis of cytokines in major depression. Biol Psychiatry, 2010. 67(5): p. 446-57. [DOI:10.1016/j.biopsych.2009.09.033]

50. McFarland, D.C., et al., Prognosis in metastatic lung cancer: vitamin D deficiency and depression-a cross-sectional analysis. BMJ Support Palliat Care, 2022. 12(3): p. 339-346. [DOI:10.1136/bmjspcare-2020-002457]

51. Akpınar, Ş. and M.G. Karadağ, Is Vitamin D Important in Anxiety or Depression? What Is the Truth? Curr Nutr Rep, 2022. 11(4): p. 675-681. [DOI:10.1007/s13668-022-00441-0]

52. Albolushi, T., M. Bouhaimed and J. Spencer, Lower Blood Vitamin D Levels Are Associated with Depressive Symptoms in a Population of Older Adults in Kuwait: A Cross-Sectional Study. Nutrients, 2022. 14(8). [DOI:10.3390/nu14081548]

53. Libuda, L., et al., Effect of vitamin D deficiency on depressive symptoms in child and adolescent psychiatric patients: results of a randomized controlled trial. Eur J Nutr, 2020. 59(8): p. 3415-3424. [DOI:10.1007/s00394-020-02176-6]

54. Hansen, J.P., et al., Vitamin D3 supplementation and treatment outcomes in patients with depression (D3-vit-dep). BMC Res Notes, 2019. 12(1): p. 203. [DOI:10.1186/s13104-019-4218-z]

55. Wang, R., et al., The effect of vitamin D supplementation on primary depression: A meta-analysis. Journal of Affective Disorders, 2024. 344: p. 653-661. [DOI:10.1016/j.jad.2023.10.021]

56. Almeida, O.P., et al., Vitamin D concentration and its association with past, current and future depression in older men: The Health In Men Study. Maturitas, 2015. 81(1): p. 36-41. [DOI:10.1016/j.maturitas.2015.01.016]

57. Zhu, C., et al., Vitamin D supplementation improves anxiety but not depression symptoms in patients with vitamin D deficiency. Brain Behav, 2020. 10(11): p. e01760. [DOI:10.1002/brb3.1760]

58. Miller, A.H., Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun, 2009. 23(2): p. 149-58. [DOI:10.1016/j.bbi.2008.08.006]

59. Bergerot, C.D., et al., Course of distress, anxiety and depression in hematological cancer patients: Association between gender and grade of neoplasm. Palliat Support Care, 2015. 13(2): p. 115-23. [DOI:10.1017/S1478951513000849]

60. Lo, C., et al., Measuring death-related anxiety in advanced cancer: preliminary psychometrics of the Death and Dying Distress Scale. J Pediatr Hematol Oncol, 2011. 33 Suppl 2: p. S140-5. [DOI:10.1097/MPH.0b013e318230e1fd]

61. Linden, W., et al., Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender and age. J Affect Disord, 2012. 141(2-3): p. 343-51. [DOI:10.1016/j.jad.2012.03.025]

62. Saboonchi, F., et al., Changes in caseness of anxiety and depression in breast cancer patients during the first year following surgery: patterns of transiency and severity of the distress response. Eur J Oncol Nurs, 2014. 18(6): p. 598-604. [DOI:10.1016/j.ejon.2014.06.007]

63. Rodin, G., et al., Pathways to distress: the multiple determinants of depression, hopelessness and the desire for hastened death in metastatic cancer patients. Soc Sci Med, 2009. 68(3): p. 562-9. [DOI:10.1016/j.socscimed.2008.10.037]

64. Molina, Y., et al., Resilience among patients across the cancer continuum: diverse perspectives. Clin J Oncol Nurs, 2014. 18(1): p. 93-101. [DOI:10.1188/14.CJON.93-101]

65. Tedeschi RG and C. LG. Trauma and transformation: growing in the aftermath of suffering. 1995; Available from: https://sk.sagepub.com/books/trauma-and-transformation. [DOI:10.4135/9781483326931]

66. Lechner, S.C., et al., Do sociodemographic and disease-related variables influence benefit-finding in cancer patients? Psychooncology, 2003. 12(5): p. 491-9. [DOI:10.1002/pon.671]

67. Lloyd, S., et al., Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival. Am J Clin Oncol, 2019. 42(4): p. 355-362. [DOI:10.1097/COC.0000000000000529]

68. Kjaer, T.K., et al., Risk of Pharmacological or Hospital Treatment for Depression in Patients with Colorectal Cancer-Associations with Pre-Cancer Lifestyle, Comorbidity and Clinical Factors. Cancers (Basel), 2021. 13(8). [DOI:10.3390/cancers13081979]

69. Festerling, L., et al., Resilience in cancer patients and how it correlates with demographics, psychological factors and lifestyle. Journal of Cancer Research and Clinical Oncology, 2023. 149(8): p. 5279-5287. [DOI:10.1007/s00432-022-04480-6]

70. Macía, P., et al., Expression of resilience, coping and quality of life in people with cancer. PLoS One, 2020. 15(7): p. e0236572. [DOI:10.1371/journal.pone.0236572]

71. DuHamel, K.N., et al., Trauma-focused intervention after bone marrow transplantation: A case study. Behavior Therapy, 2000. 31: p. 175-186. [DOI:10.1016/S0005-7894(00)80010-6]

72. Graça Pereira, M., A.P. Figueiredo and F.D. Fincham, Anxiety, depression, traumatic stress and quality of life in colorectal cancer after different treatments: A study with Portuguese patients and their partners. European Journal of Oncology Nursing, 2012. 16(3): p. 227-232. [DOI:10.1016/j.ejon.2011.06.006]

73. Frick, E., M. Tyroller and M. Panzer, Anxiety, depression and quality of life of cancer patients undergoing radiation therapy: a cross-sectional study in a community hospital outpatient centre. Eur J Cancer Care (Engl), 2007. 16(2): p. 130-6. [DOI:10.1111/j.1365-2354.2006.00720.x]

74. Medeiros M, O.C., Forones NM, Depression and anxiety in colorectal cancer patients. J Gastrointest Cancer, 2010. [DOI:10.1007/s12029-010-9132-5]

75. Ward, E., et al., Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin, 2008. 58(1): p. 9-31. [DOI:10.3322/CA.2007.0011]

76. Ubel, P.A., A.P. Abernethy and S.Y. Zafar, Full disclosure--out-of-pocket costs as side effects. N Engl J Med, 2013. 369(16): p. 1484-6. [DOI:10.1056/NEJMp1306826]

77. Zafar, S.Y., et al., The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist, 2013. 18(4): p. 381-90. [DOI:10.1634/theoncologist.2012-0279]

78. Schoen, C., et al., Affordable Care Act reforms could reduce the number of underinsured US adults by 70 percent. Health Aff (Millwood), 2011. 30(9): p. 1762-71. [DOI:10.1377/hlthaff.2011.0335]

79. Asebedo, S.D. and M.J. Wilmarth, Does how we feel about financial strain matter for mental health? Journal of financial therapy, 2017. 8(1): p. 5. [DOI:10.4148/1944-9771.1130]

80. Bradshaw, M. and C.G. Ellison, Financial hardship and psychological distress: exploring the buffering effects of religion. Soc Sci Med, 2010. 71(1): p. 196-204. [DOI:10.1016/j.socscimed.2010.03.015]

81. Marshall, G.L., et al., The price of mental well-being in later life: the role of financial hardship and debt. Aging Ment Health, 2021. 25(7): p. 1338-1344. [DOI:10.1080/13607863.2020.1758902]

82. Mahjoubi, B., et al., A cross-sectional survey of quality of life in colostomates: a report from Iran. Health Qual Life Outcomes, 2012. 10: p. 136. [DOI:10.1186/1477-7525-10-136]

83. Kovoor, J.G., et al., Depression after stoma surgery: a systematic review and meta-analysis. BMC Psychiatry, 2023. 23(1): p. 352. [DOI:10.1186/s12888-023-04871-0]

84. Vonk-Klaassen, S.M., et al., Ostomy-related problems and their impact on quality of life of colorectal cancer ostomates: a systematic review. Qual Life Res, 2016. 25(1): p. 125-33. [DOI:10.1007/s11136-015-1050-3]

85. Cannell, J.J., W.B. Grant and M.F. Holick, Vitamin D and inflammation. Dermatoendocrinol, 2014. 6(1): p. e983401. [DOI:10.4161/19381980.2014.983401]

86. Kim, H. and E. Giovannucci, Vitamin D Status and Cancer Incidence, Survival and Mortality. Adv Exp Med Biol, 2020. 1268: p. 39-52. [DOI:10.1007/978-3-030-46227-7_3]

87. Ng, K., et al., Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol, 2011. 29(12): p. 1599-606. [DOI:10.1200/JCO.2010.31.7255]

88. Bao, Y., et al., Vitamin D Status and Survival in Stage II-III Colorectal Cancer. Front Oncol, 2020. 10: p. 581597. [DOI:10.3389/fonc.2020.581597]

89. Na, S.Y., et al., Vitamin D and Colorectal Cancer: Current Perspectives and Future Directions. J Cancer Prev, 2022. 27(3): p. 147-156. [DOI:10.15430/JCP.2022.27.3.147]

90. Ng, K., et al., Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol, 2008. 26(18): p. 2984-91. [DOI:10.1200/JCO.2007.15.1027]

91. Mezawa, H., et al., Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study. BMC Cancer, 2010. 10: p. 347. [DOI:10.1186/1471-2407-10-347]

92. Deeb, K.K., D.L. Trump and C.S. Johnson, Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer, 2007. 7(9): p. 684-700. [DOI:10.1038/nrc2196]

93. Zhang, Y., J. Zhang and G.P. Studzinski, AKT pathway is activated by 1, 25-dihydroxyvitamin D3 and participates in its anti-apoptotic effect and cell cycle control in differentiating HL60 cells. Cell Cycle, 2006. 5(4): p. 447-51. [DOI:10.4161/cc.5.4.2467]

94. Posner, G.H., et al., Potent, low-calcemic, selective inhibitors of CYP24 hydroxylase: 24-sulfone analogs of the hormone 1alpha,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol, 2004. 89-90(1-5): p. 5-12. [DOI:10.1016/j.jsbmb.2004.03.044]

95. Sheinin, Y., et al., In situ mRNA hybridization analysis and immunolocalization of the vitamin D receptor in normal and carcinomatous human colonic mucosa: relation to epidermal growth factor receptor expression. Virchows Arch, 2000. 437(5): p. 501-7. [DOI:10.1007/s004280000275]

96. Kallay, E., et al., Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis, 2001. 22(9): p. 1429-35. [DOI:10.1093/carcin/22.9.1429]

97. Kállay, E., et al., Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food Chem Toxicol, 2002. 40(8): p. 1191-6. [DOI:10.1016/S0278-6915(02)00030-3]

98. Fakih, M.G., et al., Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Colorectal Dis, 2009. 24(2): p. 219-24. [DOI:10.1007/s00384-008-0593-y]

99. Ramakrishnan, S., et al., Association among plasma 1,25(OH)(2) D, ratio of 1,25(OH)(2) D to 25(OH)D and prostate cancer aggressiveness. Prostate, 2019. 79(10): p. 1117-1124. [DOI:10.1002/pros.23824]

100. Huang, R., J. Xiang and P. Zhou, Vitamin D, gut microbiota and radiation-related resistance: a love-hate triangle. J Exp Clin Cancer Res, 2019. 38(1): p. 493. [DOI:10.1186/s13046-019-1499-y]

101. Cong, J., et al., A Pilot Study: Changes of Gut Microbiota in Post-surgery Colorectal Cancer Patients. Front Microbiol, 2018. 9: p. 2777. [DOI:10.3389/fmicb.2018.02777]

102. Deng, X., et al., Comparison of Microbiota in Patients Treated by Surgery or Chemotherapy by 16S rRNA Sequencing Reveals Potential Biomarkers for Colorectal Cancer Therapy. Front Microbiol, 2018. 9: p. 1607. [DOI:10.3389/fmicb.2018.01607]

103. Bora, S.A., et al., The Gut Microbiota Regulates Endocrine Vitamin D Metabolism through Fibroblast Growth Factor 23. Front Immunol, 2018. 9: p. 408. [DOI:10.3389/fimmu.2018.00408]

104. Ralls, M.W., E. Miyasaka and D.H. Teitelbaum, Intestinal microbial diversity and perioperative complications. JPEN J Parenter Enteral Nutr, 2014. 38(3): p. 392-9. [DOI:10.1177/0148607113486482]